Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Free Cash Flow (2022 - 2026)

Zentalis Pharmaceuticals has reported Free Cash Flow over the past 5 years, most recently at -$33.0 million for Q1 2026.

  • For Q1 2026, Free Cash Flow fell 1.08% year-over-year to -$33.0 million; the TTM value through Mar 2026 reached -$125.6 million, up 17.21%, while the annual FY2025 figure was -$125.2 million, 26.79% up from the prior year.
  • Free Cash Flow for Q1 2026 was -$33.0 million at Zentalis Pharmaceuticals, down from -$30.9 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$27.0 million in Q3 2025 and troughed at -$79.6 million in Q2 2023.
  • A 5-year average of -$41.4 million and a median of -$38.8 million in 2023 define the central range for Free Cash Flow.
  • Biggest five-year swings in Free Cash Flow: plummeted 85.57% in 2023 and later soared 55.62% in 2024.
  • Year by year, Free Cash Flow stood at -$37.5 million in 2022, then fell by 8.76% to -$40.8 million in 2023, then increased by 2.62% to -$39.7 million in 2024, then rose by 22.07% to -$30.9 million in 2025, then dropped by 6.63% to -$33.0 million in 2026.
  • Business Quant data shows Free Cash Flow for ZNTL at -$33.0 million in Q1 2026, -$30.9 million in Q4 2025, and -$27.0 million in Q3 2025.